Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.

Eloranta S, Brånvall E, Celsing F, Papworth K, Ljungqvist M, Enblad G, Ekström-Smedby K.

Eur J Haematol. 2018 Jan;100(1):61-68. doi: 10.1111/ejh.12980. Epub 2017 Oct 25.

PMID:
28983970
2.

Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study.

Büsch K, Ludvigsson JF, Ekström-Smedby K, Ekbom A, Askling J, Neovius M.

Aliment Pharmacol Ther. 2014 Jan;39(1):57-68. doi: 10.1111/apt.12528. Epub 2013 Oct 16.

3.

Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis.

Monnereau A, Glaser SL, Schupp CW, Ekström Smedby K, de Sanjosé S, Kane E, Melbye M, Forétova L, Maynadié M, Staines A, Becker N, Nieters A, Brennan P, Boffetta P, Cocco P, Glimelius I, Clavel J, Hjalgrim H, Chang ET.

Blood. 2013 Nov 14;122(20):3492-9. doi: 10.1182/blood-2013-04-497586. Epub 2013 Sep 9.

4.

No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients.

Ingvar Å, Ekström Smedby K, Lindelöf B, Fernberg P, Bellocco R, Tufveson G, Höglund P, Adami J.

Acta Derm Venereol. 2012 Nov;92(6):609-14. doi: 10.2340/00015555-1271.

5.

Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease.

Elfström P, Granath F, Ekström Smedby K, Montgomery SM, Askling J, Ekbom A, Ludvigsson JF.

J Natl Cancer Inst. 2011 Mar 2;103(5):436-44. doi: 10.1093/jnci/djq564. Epub 2011 Feb 2.

PMID:
21289299
6.

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.

Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6400-5. doi: 10.1073/pnas.0915054107. Epub 2010 Mar 22.

7.

Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.

Fernberg P, Chang ET, Duvefelt K, Hjalgrim H, Eloranta S, Sørensen KM, Porwit A, Humphreys K, Melbye M, Ekström Smedby K.

Cancer Causes Control. 2010 May;21(5):759-69. doi: 10.1007/s10552-010-9504-y. Epub 2010 Jan 20.

PMID:
20087644
8.

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W.

Blood. 2008 Apr 15;111(8):4029-38. doi: 10.1182/blood-2007-10-119974. Epub 2008 Feb 8.

9.

Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study.

Hjalgrim H, Ekström-Smedby K, Rostgaard K, Amini RM, Molin D, Hamilton-Dutoit S, Schöllkopf C, Chang ET, Ralfkiaer E, Adami HO, Glimelius B, Melbye M.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1561-6.

10.

Epidemiology and etiology of non-Hodgkin lymphoma--a review.

Ekström-Smedby K.

Acta Oncol. 2006;45(3):258-71. Review.

PMID:
16644568

Supplemental Content

Loading ...
Support Center